Recruiting Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma NCT06498648 Conditions Advanced Dedifferentiated Liposarcoma, Advanced Leiomyosarcoma, Advanced Soft Tissue Sarcoma, +13 more Locations UT MD Anderson Cancer Center — Houston, Texas, United States View Trial Details
Recruiting Zanzalintinib Combined With Eribulin in Advanced Liposarcoma and Leiomyosarcoma NCT06957431 Conditions Adipocytic Sarcoma, Advanced Leiomyosarcoma, Advanced Liposarcoma, +4 more Locations Washington University School of Medicine — St Louis, Missouri, United States View Trial Details
Enrolling by Invitation A Trial for Advanced Leiomyosarcoma With Human Organoid-guided Personalized Efficacy NCT07405346 Conditions Advanced Leiomyosarcoma Locations Union Hospital, Tongji Medical College, Huazhong University of Science and Technology — Wuhan, Hubei, China View Trial Details
Active, Not Recruiting Lurbinectedin + Doxorubicin In Leiomyosarcoma NCT05099666 Conditions Advanced Leiomyosarcoma, Advanced Soft-tissue Sarcoma, Leiomyosarcoma Metastatic, +5 more Locations Mayo Arizona — Phoenix, Arizona, United States Mayo Jacksonville — Jacksonville, Florida, United States Massachusetts General Hospital — Boston, Massachusetts, United States Dana Farber Cancer Institute — Boston, Massachusetts, United States View more locations Show fewer locations Loading locations... View Trial Details
